BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10595252)

  • 1. Clinical genetic services for familial breast cancer in Poland.
    Gronwald J; Menkiszak J; Huzarski T; Byrski T; Jakubowska A; Zajàczek S; Toloczko A; Podolski J; Górecka B; Zdziebkowska H; Stanislawski P; Stawicka M; Lubinski J
    Dis Markers; 1999 Oct; 15(1-3):46. PubMed ID: 10595252
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular cancer genetics in eastern and central Europe.
    Olah E
    Dis Markers; 1999 Oct; 15(1-3):75-7. PubMed ID: 10595256
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial breast cancer: clinical services in The Netherlands.
    Menko FH
    Dis Markers; 1999 Oct; 15(1-3):31-3. PubMed ID: 10595247
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial breast and ovarian cancer: genetic counseling and clinical management in Italy.
    Pasini B; Pierotti MA
    Dis Markers; 1999 Oct; 15(1-3):41-3. PubMed ID: 10595250
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer genetics services in Europe.
    Hodgson S; Milner B; Brown I; Bevilacqua G; Chang-Claude J; Eccles D; Evans G; Gregory H; Møller P; Morrison P; Steel M; Stoppa-Lyonnet D; Vasen H; Haites N
    Dis Markers; 1999 Oct; 15(1-3):3-13. PubMed ID: 10595245
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer genetics services in the UK.
    Hodgson SV
    Dis Markers; 1999 Oct; 15(1-3):44-5. PubMed ID: 10595251
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic nurses and counsellors--preparation for practice with families at risk of familial cancer.
    Skirton H
    Dis Markers; 1999 Oct; 15(1-3):145-7. PubMed ID: 10595269
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
    Møller P; Evans G; Haites N; Vasen H; Reis MM; Anderson E; Apold J; Hodgson S; Eccles D; Olsson H; Stoppa-Lyonnet D; Chang-Claude J; Morrison PJ; Bevilacqua G; Heimdal K; Maehle L; Lalloo F; Gregory H; Preece P; Borg A; Nevin NC; Caligo M; Steel CM
    Dis Markers; 1999 Oct; 15(1-3):207-11. PubMed ID: 10595280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer genetics services in Northern Ireland.
    Morrison PJ; Nevin NC
    Dis Markers; 1999 Oct; 15(1-3):37-40. PubMed ID: 10595249
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
    Stoppa-Lyonnet D; Caligo M; Eccles D; Evans DG; Haites NE; Hodgson NS; Møller P; Morrison PJ; Steel CM; Vasen HF; Chang-Claude J
    Dis Markers; 1999 Oct; 15(1-3):67-8. PubMed ID: 10595254
    [No Abstract]   [Full Text] [Related]  

  • 11. Costs and benefits of diagnosing familial breast cancer.
    Heimdal K; Maehle L; Møller P
    Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
    Sobol H; Bignon YJ; Bonaiti C; Cuisenier J; Lasset C; Lortholary A; Noguès C; Stoppa-Lyonnet D; Eisinger F
    Dis Markers; 1999 Oct; 15(1-3):15-29. PubMed ID: 10595246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of DNA diagnostics.
    Critchfield GC
    Dis Markers; 1999 Oct; 15(1-3):108-11. PubMed ID: 10595261
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.
    Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D
    Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group.
    Eccles DM; Simmonds P; Goddard J; Coultas M; Lalloo F; Evans G; Haites N
    Dis Markers; 1999 Oct; 15(1-3):187-9. PubMed ID: 10595276
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic testing for familial breast cancer--ethical questions concerning individual rights and social responsibility.
    Graumann S
    Dis Markers; 1999 Oct; 15(1-3):136-8. PubMed ID: 10595267
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic Counseling.
    Brekelmans CT; Bartels CC; Crepin E; van Geel AN; Meijers-Heijboer H; Seynaeve C; Tilanus-Linthorst MM; Verhoog LC; Wagner A; Klijn JG
    Dis Markers; 1999 Oct; 15(1-3):34-6. PubMed ID: 10595248
    [No Abstract]   [Full Text] [Related]  

  • 18. [Genetic predisposition for breast carcinoma: overview of molecular genetic principles from long familial epidemiologic observation].
    Krainer M; Zojer N; Mannhalter C
    Geburtshilfe Frauenheilkd; 1995 Jul; 55(7):M73-6. PubMed ID: 7557194
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.
    Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K
    Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic testing.
    Petersen GM
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):939-52. PubMed ID: 10949782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.